EIF2AK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.801200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.505000E-01
Normal-vs-Stage2
8.789800E-01
Normal-vs-Stage3
4.149700E-02
Normal-vs-Stage4
1.638040E-01
Stage1-vs-Stage2
7.432000E-01
Stage1-vs-Stage3
2.402600E-01
Stage1-vs-Stage4
4.988600E-01
Stage2-vs-Stage3
2.465600E-01
Stage2-vs-Stage4
2.217000E-01
Stage3-vs-Stage4
5.123900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.680000E-01
Normal-vs-AfricanAmerican
4.833400E-01
Normal-vs-Asian
3.321200E-01
Caucasian-vs-AfricanAmerican
9.146300E-02
Caucasian-vs-Asian
1.605230E-01
AfricanAmerican-vs-Asian
5.109600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.696600E-01
Normal-vs-Female
8.999400E-01
Male-vs-Female
8.606800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.580200E-01
Normal-vs-Age(41-60Yrs)
8.542200E-01
Normal-vs-Age(61-80Yrs)
8.008600E-01
Normal-vs-Age(81-100Yrs)
4.917400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.767200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.688800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.875400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.250020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.122380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.956000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.899000E-01
Normal-vs-Daily Drinker
1.566020E-01
Normal-vs-Weekly Drinker
6.525000E-01
Normal-vs-Occasional Drinker
9.530000E-01
Normal-vs-Social Drinker
8.222600E-01
Non Drinker-vs-Daily Drinker
1.867590E-01
Non Drinker-vs-Weekly Drinker
9.623000E-01
Non Drinker-vs-Occasional Drinker
1.982360E-01
Non Drinker-vs-Social Drinker
1.996410E-01
Daily Drinker-vs-Weekly Drinker
4.754600E-01
Daily Drinker-vs-Occasional Drinker
4.260200E-02
Daily Drinker-vs-Social Drinker
5.364100E-02
Weekly Drinker-vs-Occasional Drinker
3.716000E-01
Weekly Drinker-vs-Social Drinker
2.891400E-01
Occasional Drinker-vs-Social Drinker
7.384000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.255500E-02
Normal-vs-Grade 2
3.058200E-02
Normal-vs-Grade 3
5.634500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.045800E-01
Grade 1-vs-Grade 3
7.037000E-01
Grade 1-vs-Grade 4
9.255500E-02
Grade 2-vs-Grade 3
4.894000E-01
Grade 2-vs-Grade 4
3.058200E-02
Grade 3-vs-Grade 4
5.634500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.246000E-01
Normal-vs-NonDiabetic
6.333800E-01
Diabetic-vs-NonDiabetic
4.518800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.564400E-01
Normal-vs-NoPancreatitis
7.434600E-01
Pancreatitis-vs-NoPancreatitis
6.260200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.128800E-01
Normal-vs-N1
9.041200E-01
N0-vs-N1
9.865200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.610600E-01
Normal-vs-TP53-NonMutant
6.798400E-01
TP53-Mutant-vs-TP53-NonMutant
1.538410E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
